BibTex RIS Kaynak Göster

L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor

Yıl 2012, Cilt: 4 Sayı: 3, 1 - 6, 01.08.2012

Öz

It is known that the production of free O2 radicals and oxidation products have a significant increase in patients with cancer. There are endogeneous protection systems in order to remove free O2 radicals. One of these endogeneous protection system is carnitine. Carnitine has an important role in muscle functions and in obtaining energy from the membranes of body cells.
This study aims to investigate the role of L-carnitine, L-propionyl carnitine and malondialdehyde (MDA) in antioxidant mechanism in children recently diagnosed with solid tumor. The study group were consisted from 57 children from 2 children's cancer centers (Gazi University Pediatrics Department and Sami Ulus Pediatrics Hospital) who were recently diagnosed with solid tumor and 45 healthy control. There was no significant difference in free carnitine and L-propionyl carnitine levels between patients with solid tumor and healthy controls. But, MDA levels were significantly higher in children with recently diagnosed solid tumor than in healthy controls.

Yıl 2012, Cilt: 4 Sayı: 3, 1 - 6, 01.08.2012

Öz

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Original Articles
Yazarlar

Arzu Okur

Yayımlanma Tarihi 1 Ağustos 2012
Yayımlandığı Sayı Yıl 2012 Cilt: 4 Sayı: 3

Kaynak Göster

APA Okur, A. (2012). L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences, 4(3), 1-6. https://doi.org/10.17334/jps.77916
AMA Okur A. L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences. Eylül 2012;4(3):1-6. doi:10.17334/jps.77916
Chicago Okur, Arzu. “L-Carnitine, L-Propionyl Carnitine and Malondialdehyde Levels of Pediatric Patients With Solid Tumor”. Journal of Pediatric Sciences 4, sy. 3 (Eylül 2012): 1-6. https://doi.org/10.17334/jps.77916.
EndNote Okur A (01 Eylül 2012) L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences 4 3 1–6.
IEEE A. Okur, “L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor”, Journal of Pediatric Sciences, c. 4, sy. 3, ss. 1–6, 2012, doi: 10.17334/jps.77916.
ISNAD Okur, Arzu. “L-Carnitine, L-Propionyl Carnitine and Malondialdehyde Levels of Pediatric Patients With Solid Tumor”. Journal of Pediatric Sciences 4/3 (Eylül 2012), 1-6. https://doi.org/10.17334/jps.77916.
JAMA Okur A. L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences. 2012;4:1–6.
MLA Okur, Arzu. “L-Carnitine, L-Propionyl Carnitine and Malondialdehyde Levels of Pediatric Patients With Solid Tumor”. Journal of Pediatric Sciences, c. 4, sy. 3, 2012, ss. 1-6, doi:10.17334/jps.77916.
Vancouver Okur A. L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences. 2012;4(3):1-6.